Cardiogenic Shock
📧 Sign up to get email alerts when something new happens for Cardiogenic Shock.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Prognostic Value of the Rockwood Clinical Frailty Score in Cardiogenic Shock
This study evaluates whether the Rockwood Clinical Frailty Score has prognostic value for outcomes in cardiogenic shock and is currently rec…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Clinical Outcomes of Contemporary IMPELLA Devices in Cardiogenic Shock and High-risk Percutaneous Coronary Intervention
This clinical trial update discusses clinical outcomes of contemporary IMPELLA devices in patients with cardiogenic shock and high-risk perc…
-
CLINICAL_TRIALS withdrawal · 2024-11-12Clinical Trial Update: Establishing Physiologic Outcomes for Ventricular Unloading on VA ECMO
A clinical trial evaluating physiologic outcomes for ventricular unloading on VA ECMO, targeting patients with cardiogenic shock, has been w…
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator [Phase 4]
Phase 4 clinical trial update from Samsung Medical Center assessing revascularization strategies for patients with acute myocardial infarcti…
-
FDA approval · 2024-11-05FDA Approved: DOPAMINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for dopamine hydrochloride injectable from Hikma Pharmaceuticals USA Inc., confirming continued appr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Cardiac Rehabilitation in Patients Acutely Managed for Cardiogenic Shock (ENIGMA)
A clinical trial update for ENIGMA assessing cardiac rehabilitation in patients acutely managed for cardiogenic shock is currently recruitin…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: The ECMOCYP (cytochromes P450 Activity) Study
This is a clinical trial update for the ECMOCYP study, investigating cytochrome P450 activity during ECMO support in patients with cardiogen…
-
CLINICAL_TRIALS withdrawal · 2024-10-23Clinical Trial Update: Study on Early Intra-aortic Balloon Pump Placement in Acute Decompensated Heart Failure Complicated by Cardiogenic Shock [Phase 4]
A Phase 4 trial evaluating early intra-aortic balloon pump placement in acute decompensated heart failure with cardiogenic shock has been te…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Early Left Ventricular unLoading by Impella vs Intra-aortic Balloon Pump
Clinical trial comparing early left ventricular unloading using the Impella device versus an intra-aortic balloon pump in patients with card…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Efficacy and Safety of the CorVad Percutaneous Ventricular Assist System in Cardiogenic Shock [NA]
This clinical trial update states that the CorVad Percutaneous Ventricular Assist System is currently recruiting to evaluate its efficacy an…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: IMPELLA, Complications and Tolerance
A clinical trial update indicates that the IMPELLA device is being studied for cardiogenic shock and is currently recruiting at University H…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Role of Candidate Proteins in Capillary Leakage During Acute Circulatory Failure
A clinical trial sponsored by Assistance Publique - Hôpitaux de Paris is evaluating candidate proteins involved in capillary leakage during …
-
FDA approval · 2024-10-03FDA Approved: ISOPROTERENOL HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved an original ANDA for Isoproterenol hydrochloride from Sagent Pharmaceuticals.
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Impella Real-World Surveillance of Patients Using Sodium Bicarbonate
A completed real-world surveillance study evaluating outcomes of patients treated with Impella and sodium bicarbonate in the setting of card…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: GLP-1 and Hyperoxia for Organ Protection in Heart Surgery [NA]
This clinical trial update describes a study evaluating GLP-1 and hyperoxia for organ protection during heart surgery, which is currently ac…
-
FDA approval · 2024-08-22FDA Approved: ISOPROTERENOL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for isoproterenol hydrochloride from Amneal Pharmaceuticals LLC. The action expands the approved use…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: REMAP ECMO - Beta Receptor Modulation Trial [Phase 2]
Phase 2 trial update for REMAP ECMO investigates beta receptor modulation in patients with heart failure and cardiogenic shock; the study is…
-
CLINICAL_TRIALS withdrawal · 2024-07-19Clinical Trial Update: Awake Axillary Impella 5.5 Placement - A Feasibility Trial [NA]
The feasibility trial evaluating awake axillary placement of the Impella 5.5 in cardiogenic shock has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: An Interventional Left Ventricular Assist System for Cardiogenic Shock [NA]
This clinical trial update describes an interventional left ventricular assist system being studied for cardiogenic shock, and the study is …
-
FDA approval · 2024-06-11FDA Approved: NOREPINEPHRINE BITARTRATE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for norepinephrine bitartrate from Baxter Healthcare Corporation.
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: Correlation of Cardiac Output Determined by Echocardiography and Indirect Calorimetry in Critically Ill Patients in Cardiogenic Shock on Extracorporeal Circulatory Life Support
This clinical trial update from Universität Münster is recruiting to examine the correlation between cardiac output measurements by echocard…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndrome and Non-Acute Coronary Syndrome Related Cardiogenic Shock [NA]
This clinical trial from Erasmus Medical Center investigates the clinical effects of intra-aortic balloon pump support in patients with card…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: REnal reCOVery After ECMO for Cardiogenic Shock (RECOVECMO)
RECOVECMO is a clinical trial studying renal recovery after ECMO support for cardiogenic shock; the update indicates the study status is COM…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Danish Cardiogenic Shock Trial [NA]
The Danish Cardiogenic Shock Trial (NCT01633502) is reported as completed.
-
CLINICAL_TRIALS trial_result · 2024-04-24Clinical Trial Update: Evaluation of Early CRRT InTerventions in Patients With ECMO(ELITE) [Phase 4]
Phase 4 clinical trial update evaluating early continuous renal replacement therapy interventions in patients supported with ECMO for cardio…